Gil Schwartzberg
2022
In 2022, Gil Schwartzberg earned a total compensation of $80K as Director at LIXTE BIOTECHNOLOGY HOLDINGS, a 92% decrease compared to previous year.
Compensation breakdown
| Option Awards | $63,340 |
|---|---|
| Other | $16,630 |
| Total | $79,970 |
Schwartzberg received $63.3K in option awards, accounting for 79% of the total pay in 2022.
Schwartzberg also received $16.6K in other compensation.
Rankings
In 2022, Gil Schwartzberg's compensation ranked 5,574th out of 5,690 executives tracked by ExecPay. In other words, Schwartzberg earned more than 2.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,574 out of 5,690 | 2nd |
Division Manufacturing | 3,039 out of 3,095 | 2nd |
Major group Chemicals And Allied Products | 1,385 out of 1,406 | 2nd |
Industry group Drugs | 1,290 out of 1,307 | 1st |
Industry Pharmaceutical Preparations | 935 out of 949 | 2nd |
Source: SEC filing on November 4, 2024.
Schwartzberg's colleagues
We found six more compensation records of executives who worked with Gil Schwartzberg at LIXTE BIOTECHNOLOGY HOLDINGS in 2022.
2022
Bas der Baan
LIXTE BIOTECHNOLOGY HOLDINGS
Director
2022
René Bernards
LIXTE BIOTECHNOLOGY HOLDINGS
Director
2022
Yun Yen
LIXTE BIOTECHNOLOGY HOLDINGS
Director
2022
Regina Brown
LIXTE BIOTECHNOLOGY HOLDINGS
Director
2022
Stephen Forman
LIXTE BIOTECHNOLOGY HOLDINGS
Director
2022
Philip Palmedo
LIXTE BIOTECHNOLOGY HOLDINGS